Please provide your email address to receive an email when new articles are posted on . “There are no clear data to suggest that allopurinol is detrimental to renal function in patients with gout,” ...

Improvement observed in estimated glomerular filtration rate in kidney transplant recipients treated with allopurinol for elevated uric acid. Urate-lowering treatment with allopurinol may help ...

Trial subgroup analyses support the use of either allopurinol or febuxostat in patients with stage 3 CKD and gout. A prespecified analysis of the STOP-GOUT trial revealed that allopurinol has similar ...

The 2012 American College of Rheumatology gout treatment guidelines recommend titration of urate-lowering medication doses to achieve target serum uric acid (sUA) levels of less than 6 mg/dL. Analysis ...

Allopurinol didn't provide renal protection, according to the results of two randomized trials. Researchers have long debated whether hyperuricemia causes decline in renal function. In two randomized ...

The effects of allopurinol treatment on mortality among patients with gout remain uncertain, with a new meta-analysis finding conflicting results. In a systematic review of the literature that ...

December 16, 2011 — A retrospective analysis of data from 222 hyperuricemic women with gout who had participated in phase 3 comparative trials showed that febuxostat, 80 mg/d, was more effective than ...

Allopurinol (Alpuric) is prescribed to treat gouty arthritis and prevent specific kidney stones by reducing high uric acid levels in the blood. Allopurinol (Alpuric) is a xanthine oxidase inhibitor, ...

Indoco Remedies Ltd has informed BSE that the Company has received the approval from United States Food & Drug Administration (USFDA) to manufacture and market Allopurinol 100 mg & 300 mg ...

Background A 67-year-old man presented to a rheumatology clinic with a 1-week history of severe pain and swelling of his right knee. He had been receiving allopurinol for about 5 months for the ...

BACKGROUND: Allopurinol is commonly prescribed for gout, and its clinical use may expand with ongoing trials assessing its potential cardiorenal benefits. Because heart disease has been suggested to ...